Identifying Factors That Influence the Use of Pathogen Genomics in Australia and New Zealand: a Protocol

Overview

Journal Front Public Health

Specialty Public Health

Date 2024 Nov 7

PMID 39507654

Authors

James D H Ong

Tehzeeb Zulfiqar

Kathryn Glass

Martyn D Kirk

Brad Astbury

Angeline Ferdinand

Affiliations

Soon will be listed here.

Abstract

Introduction: Pathogen genomics, where whole genome sequencing technologies are used to produce complete genomic sequences of pathogens, is being increasingly used for infectious disease surveillance and outbreak response. Although proof-of-concept studies have highlighted the viability of using pathogen genomics in public health, few studies have investigated how end-users utilize pathogen genomics in public health. We describe a protocol for a study that aims to identify key factors that influence the use of pathogen genomics to inform public health responses against infectious diseases in Australia and New Zealand.

Methods: We will use qualitative comparative analysis (QCA), a case-oriented methodology that systematically compares and analyses multiple cases (or 'units of analysis'), to identify multiple pathways leading to the use of pathogen genomics results in public health actions. As part of the process, we will develop a rubric to identify and define the use of pathogen genomics and individual factors affecting this process. Simultaneously, we will identify cases where pathogen genomics has been used in public health across Australia and New Zealand. Data for these cases will be collected from document review of publicly available and confidential documents and semi-structured interviews with technicians and end-users and summarized in a case report. These case reports will form the basis for scoring each case on the extent of the use of pathogen genomics data and the presence or absence of specific factors such as the ease of extracting essential information from pathogen genomics reports and perceptions toward pathogen genomics. Using the scores, cases will be analyzed using QCA techniques to identify pathways leading to the use of pathogen genomics data. These pathways will be interpreted alongside the cases to provide rich explanations of the use of pathogen genomics in public health.

Discussion: This study will improve our understanding of the key factors that facilitate or hinder the use of pathogen genomics to inform public health authorities and end-users. These findings may inform ways to enhance the use of pathogen genomics data in public health.

References

Leekitcharoenphon P, Nielsen E, Kaas R, Lund O, Aarestrup F . Evaluation of whole genome sequencing for outbreak detection of Salmonella enterica. PLoS One. 2014; 9(2):e87991. PMC: 3913712. DOI: 10.1371/journal.pone.0087991. View

Kwong J, Mercoulia K, Tomita T, Easton M, Li H, Bulach D . Prospective Whole-Genome Sequencing Enhances National Surveillance of Listeria monocytogenes. J Clin Microbiol. 2015; 54(2):333-42. PMC: 4733179. DOI: 10.1128/JCM.02344-15. View

Lin C, da Silva E, Sahukhan A, Palou T, Buadromo E, Hoang T . Towards Equitable Access to Public Health Pathogen Genomics in the Western Pacific. Lancet Reg Health West Pac. 2021; 18:100321. PMC: 8610764. DOI: 10.1016/j.lanwpc.2021.100321. View

Ford L, Carter G, Wang Q, Seemann T, Sintchenko V, Glass K . Incorporating Whole-Genome Sequencing into Public Health Surveillance: Lessons from Prospective Sequencing of Salmonella Typhimurium in Australia. Foodborne Pathog Dis. 2018; 15(3):161-167. DOI: 10.1089/fpd.2017.2352. View

Tornheim J, Starks A, Rodwell T, Gardy J, Walker T, Cirillo D . Building the Framework for Standardized Clinical Laboratory Reporting of Next-generation Sequencing Data for Resistance-associated Mutations in Mycobacterium tuberculosis Complex. Clin Infect Dis. 2019; 69(9):1631-1633. PMC: 6792097. DOI: 10.1093/cid/ciz219. View

Chattaway M, Dallman T, Larkin L, Nair S, McCormick J, Mikhail A . The Transformation of Reference Microbiology Methods and Surveillance for With the Use of Whole Genome Sequencing in England and Wales. Front Public Health. 2019; 7:317. PMC: 6881236. DOI: 10.3389/fpubh.2019.00317. View

Crisan A, McKee G, Munzner T, Gardy J . Evidence-based design and evaluation of a whole genome sequencing clinical report for the reference microbiology laboratory. PeerJ. 2018; 6:e4218. PMC: 5767084. DOI: 10.7717/peerj.4218. View

Stevens E, Carleton H, Beal J, Tillman G, Lindsey R, Lauer A . Use of Whole Genome Sequencing by the Federal Interagency Collaboration for Genomics for Food and Feed Safety in the United States. J Food Prot. 2022; 85(5):755-772. DOI: 10.4315/JFP-21-437. View

Whaley M, Joseph S, Retchless A, Kretz C, Blain A, Hu F . Whole genome sequencing for investigations of meningococcal outbreaks in the United States: a retrospective analysis. Sci Rep. 2018; 8(1):15803. PMC: 6202316. DOI: 10.1038/s41598-018-33622-5. View

10.

Beukers A, Jenkins F, van Hal S . Centralised or Localised Pathogen Whole Genome Sequencing: Lessons Learnt From Implementation in a Clinical Diagnostic Laboratory. Front Cell Infect Microbiol. 2021; 11:636290. PMC: 8169965. DOI: 10.3389/fcimb.2021.636290. View

11.

Carter L, Yu M, Sacks J, Barnadas C, Pereyaslov D, Cognat S . Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022-2032. Bull World Health Organ. 2022; 100(4):239-239A. PMC: 8958828. DOI: 10.2471/BLT.22.288220. View

12.

Kwong J, McCallum N, Sintchenko V, Howden B . Whole genome sequencing in clinical and public health microbiology. Pathology. 2015; 47(3):199-210. PMC: 4389090. DOI: 10.1097/PAT.0000000000000235. View

13.

Levy A, Gazeley J, Lee T, Jardine A, Gordon C, Cooper N . Whole genome sequencing of SARS-CoV-2 from wastewater links to individual cases in catchments. Sci Total Environ. 2022; 851(Pt 2):158266. PMC: 9398818. DOI: 10.1016/j.scitotenv.2022.158266. View

14.

Eustace M, Sud A, Thompson C, Schlebusch S, Horvath R . Responding to the COVID-19 pandemic in real time: coordinating a local hospital response using whole genome sequencing of SARS-CoV-2. Med J Aust. 2022; 217(10):546-547. PMC: 9874709. DOI: 10.5694/mja2.51762. View

15.

Allard M, Strain E, Melka D, Bunning K, Musser S, Brown E . Practical Value of Food Pathogen Traceability through Building a Whole-Genome Sequencing Network and Database. J Clin Microbiol. 2016; 54(8):1975-83. PMC: 4963501. DOI: 10.1128/JCM.00081-16. View

16.

Van Goethem N, Struelens M, De Keersmaecker S, Roosens N, Robert A, Quoilin S . Perceived utility and feasibility of pathogen genomics for public health practice: a survey among public health professionals working in the field of infectious diseases, Belgium, 2019. BMC Public Health. 2020; 20(1):1318. PMC: 7456758. DOI: 10.1186/s12889-020-09428-4. View

17.

Waddington C, Carey M, Boinett C, Higginson E, Veeraraghavan B, Baker S . Exploiting genomics to mitigate the public health impact of antimicrobial resistance. Genome Med. 2022; 14(1):15. PMC: 8849018. DOI: 10.1186/s13073-022-01020-2. View

18.

Gomes L, Campino S, Marinho C, Clark T, Phelan J . Whole genome sequencing reveals large deletions and other loss of function mutations in drug resistance genes. Microb Genom. 2021; 7(12). PMC: 8767347. DOI: 10.1099/mgen.0.000724. View

19.

Seemann T, Lane C, Sherry N, Duchene S, Goncalves da Silva A, Caly L . Tracking the COVID-19 pandemic in Australia using genomics. Nat Commun. 2020; 11(1):4376. PMC: 7462846. DOI: 10.1038/s41467-020-18314-x. View

20.

McDonnell J, Dallman T, Atkin S, Turbitt D, Connor T, Grant K . Retrospective analysis of whole genome sequencing compared to prospective typing data in further informing the epidemiological investigation of an outbreak of Shigella sonnei in the UK. Epidemiol Infect. 2013; 141(12):2568-75. PMC: 9151367. DOI: 10.1017/S0950268813000137. View